Literature DB >> 1985759

Clinicopathologic characteristics of adenosquamous carcinoma of the lung.

S Takamori1, M Noguchi, S Morinaga, T Goya, S Tsugane, T Kakegawa, Y Shimosato.   

Abstract

Fifty-six cases of surgically resected adenosquamous carcinoma of the lung were studied clinicopathologically, and their outcome was compared with that of adenocarcinomas and squamous cell carcinomas of the lung. The frequency rate of adenosquamous carcinoma was 2.6% of 2160 primary lung cancers resected in the National Cancer Center Hospital (Tokyo, Japan). The survival curves of patients with adenosquamous carcinomas, adenocarcinomas, and squamous cell carcinomas indicated that the outcome of adenosquamous carcinoma was poorer than that of adenocarcinomas and squamous cell carcinomas, particularly in Stages I and II. The amount of adenocarcinoma component did not affect the survival rate, although the histologic features of metastatic lymph nodes was somewhat influenced by the histologic type of the primary tumors. The histologic subtype of adenosquamous carcinoma was one of the independent prognostic determinants.

Entities:  

Mesh:

Year:  1991        PMID: 1985759     DOI: 10.1002/1097-0142(19910201)67:3<649::aid-cncr2820670321>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma.

Authors:  Jamie E Chaft; Natasha Rekhtman; Marc Ladanyi; Gregory J Riely
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

3.  Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.

Authors:  Natasha Rekhtman; Paul K Paik; Maria E Arcila; Laura J Tafe; Geoffrey R Oxnard; Andre L Moreira; William D Travis; Maureen F Zakowski; Mark G Kris; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

4.  Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.

Authors:  H Kanazawa; M Ebina; N Ino-Oka; M Shimizukawa; T Takahashi; S Fujimura; T Imai; T Nukiwa
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

5.  Human papillomavirus DNA in adenosquamous carcinoma of the lung.

Authors:  K Tsuhako; I Nakazato; T Hirayasu; H Sunakawa; T Iwamasa
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

6.  Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: risk of coexistent double cancer.

Authors:  Hidetaka Uramoto; Sohsuke Yamada; Takeshi Hanagiri
Journal:  J Cardiothorac Surg       Date:  2010-10-29       Impact factor: 1.637

7.  Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.

Authors:  Hirotake Komatsu; Shinichi Egawa; Fuyuhiko Motoi; Takanori Morikawa; Naoaki Sakata; Takeshi Naitoh; Yu Katayose; Kazuyuki Ishida; Michiaki Unno
Journal:  Surg Today       Date:  2014-06-29       Impact factor: 2.549

8.  Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type?

Authors:  Erik Vassella; Stephanie Langsch; Matthias S Dettmer; Cornelia Schlup; Maja Neuenschwander; Milo Frattini; Mathias Gugger; Stephan C Schäfer
Journal:  Oncotarget       Date:  2015-09-15

9.  A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan.

Authors:  Yuan-Tzu Lan; Kuo-Hung Huang; Chien-An Liu; Ling-Chen Tai; Ming-Huang Chen; Yee Chao; Anna Fen-Yau Li; Shih-Hwa Chiou; Yi-Ming Shyr; Chew-Wun Wu; Wen-Liang Fang
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

10.  Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer.

Authors:  Pengbo Deng; Chengping Hu; Lihua Zhou; Yuanyuan Li; Li Huang
Journal:  Mol Clin Oncol       Date:  2013-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.